ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,981Medicare Part D Prescriptions Filled, Including Refills

Rank: 116 out of 5176

$1M Total Retail Price of All Prescriptions

Rank: 261 out of 5176

575 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
94% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 575 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

8% of this provider’s 575 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 17,786 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
WARFARIN SODIUM 1,025 1,000 1 13
FUROSEMIDE 931 882 2 8
CITALOPRAM HBR 766 714 3 31
METOPROLOL TARTRATE 740 714 4 6
OMEPRAZOLE 684 658 5 3
LEVOTHYROXINE SODIUM 681 654 6 4
LISINOPRIL 636 603 7 5
DONEPEZIL HCL 488 487 8 28
SIMVASTATIN 458 425 9 1
AMLODIPINE BESYLATE 415 393 10 2
NAMENDA 303 303 11 47
MIRTAZAPINE 265 262 12 45
GABAPENTIN 262 225 13 21
METFORMIN HCL 227 225 14 7
TAMSULOSIN HCL 217 200 15 20
ISOSORBIDE MONONITRATE ER 213 210 16 44
IPRATROPIUM-ALBUTEROL 203 201 17 138
LANTUS 194 189 18 66
DIVALPROEX SODIUM 180 179 19 104
GLIPIZIDE 178 178 20 63
CARVEDILOL 177 177 21 24
SPIRONOLACTONE 175 161 22 88
QUETIAPINE FUMARATE 173 173 23 75
LACTULOSE 169 166 24 87
POLYETHYLENE GLYCOL 3350 167 154 25 74
CYMBALTA 165 138 26 90
RISPERIDONE 161 155 27 78
LEVETIRACETAM 151 139 28 92
FAMOTIDINE 145 127 29 58
PREDNISONE 136 118 30 52
SULFAMETHOXAZOLE-TRIMETHOPRIM 136 127 30 181
ATENOLOL 135 114 32 12
CARBIDOPA-LEVODOPA 131 131 33 98
SPIRIVA 129 119 34 54
EXELON 124 123 35 162
ADVAIR DISKUS 118 96 36 32
DILTIAZEM 24HR CD 115 109 37 119
LIDODERM 115 106 37 59
METOPROLOL SUCCINATE 114 112 39 11
DIGOXIN 112 112 40 56
HYDRALAZINE HCL 111 111 41 73
TRAVATAN Z 105 96 42 234
TRAZODONE HCL 102 101 43 71
OXYBUTYNIN CHLORIDE 95 81 44 227
PHENYTOIN SODIUM EXTENDED 95 83 44 232
ALLOPURINOL 93 81 46 41
CIPROFLOXACIN HCL 93 82 46 84
DIOVAN 92 90 48 19
SANTYL 91 64 49 124
FINASTERIDE 90 70 50 69
POTASSIUM CHLORIDE 90 86 50 34
BRIMONIDINE TARTRATE 87 78 52 244
ATORVASTATIN CALCIUM 86 85 53 9
NITROGLYCERIN PATCH 86 86 53 149
SEROQUEL 84 84 55 166
OLANZAPINE 84 84 55 140
TRAMADOL HCL 84 81 55 40
CLONIDINE HCL 84 71 55 79
LEVOFLOXACIN 83 74 59 109
NOVOLIN R 81 75 60 191
PAROXETINE HCL 80 80 61 93
CRESTOR 80 68 61 15
SERTRALINE HCL 79 67 63 30
HALOPERIDOL 79 60 63 145
KLOR-CON M20 78 78 65 129
NOVOLIN 70-30 77 77 66 287
CLOPIDOGREL 76 75 67 26
HYDROCHLOROTHIAZIDE 75 74 68 10
PANTOPRAZOLE SODIUM 74 72 69 61
METOCLOPRAMIDE HCL 74 70 69 176
PLAVIX 73 70 71 29
RANITIDINE HCL 71 62 72 36
HYDROCODONE-ACETAMINOPHEN 70 54 S3 73 27
HYDROCORTISONE 68 68 74 265
PRAVASTATIN SODIUM 68 68 74 23
ALENDRONATE SODIUM 65 54 76 18
LOSARTAN POTASSIUM 62 62 77 14
OXYBUTYNIN CHLORIDE ER 62 60 77 204
NITROFURANTOIN 61 60 79 343
CEFPODOXIME PROXETIL 58 52 80 399
BACLOFEN 57 45 81 173
FLUTICASONE PROPIONATE 56 49 82 38
PHENYTOIN 55 55 83 522
LATANOPROST 54 41 84 185
METHIMAZOLE 51 41 85 331
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 17, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.